Engagement of Toll‐like receptor‐2 on cytotoxic T‐lymphocytes occurs in vivo and augments antitumor activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engagement of Toll‐like receptor‐2 on cytotoxic T‐lymphocytes occurs in vivo and augments antitumor activity

Published:2008-06-27 Issue:10 Volume:22 Page:3628-3637
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Asprodites Nicole¹,Zheng Liqin¹,Geng Degui¹,Velasco‐Gonzalez Cruz²,Sanchez‐Perez Luis³,Davila Eduardo¹

Affiliation:

1. Stanley S. Scott Cancer CenterLouisiana State University Health Sciences CenterNew OrleansLouisianaUSA

2. School of Public HealthLouisiana State University Health Sciences CenterNew OrleansLouisianaUSA

3. Department of PediatricsLouisiana State University Health Sciences CenterNew OrleansLouisianaUSA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.08-108274

Reference49 articles.

1. Development of TLR9 agonists for cancer therapy

2. Recognition of pathogen-associated molecular patterns by TLR family

3. Therapeutic potential of Toll-like receptor 9 activation

4. Toll-like receptor control of the adaptive immune responses

5. Toll-Like Receptors

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy;Frontiers in Immunology;2023-10-23

2. Expression and function of toll-like receptor 2 in vertebrate;Acta Histochemica;2023-04

3. Immunostimulatory effects ofBacillus coagulansSANK70258;2023-02-21

4. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges;Frontiers in Immunology;2022-11-21

5. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8⁺ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models;Journal for ImmunoTherapy of Cancer;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3